RISE: Establishing super-Resolution Imaging in Hull for impactful multimorbidity ReSEarch MRC Equipment bid 2024 - Confocal Imaging ZEISS Elyra 7 with Lattice SIM²

Dr Leonid Nikitenko L.Nikitenko@hull.ac.uk
Lecturer in Biomedical Sciences

Mr Kevin Oxley

Dr Katie Wraith K.Wraith@hull.ac.uk
Lecturer in Cardiovascular Biology

Dr Andre Voelzmann A.Voelzmann@hull.ac.uk
Lecturer in Cell Biology & Biotechnology

Professor Tim Palmer Tim.Palmer@hull.ac.uk
HYMS Professor of Cardiovascular Biology

Professor Matthew Hardman M.Hardman@hull.ac.uk
Chair in Wound Healing / HYMS Director of Research

Professor Roger Sturmey R.Sturmey@hull.ac.uk
Professor of Reproductive Medicine

Dr Simon Calaminus S.Calaminus@hull.ac.uk
Senior Lecturer

Dr Giordano Pula G.Pula@hull.ac.uk

Dr Holly Wilkinson H.N.Wilkinson@hull.ac.uk
Lecturer in Wound Healing

Dr Amin Ardestani A.Ardestani@hull.ac.uk
Senior Lecturer

Dr Camille Ettelaie C.Ettelaie@hull.ac.uk
Lecturer

Dr Paul Hiebert P.Hiebert@hull.ac.uk
Lecturer in Wound Healing

Professor Anthony Maraveyas A.Maraveyas@hull.ac.uk
Professor in Cancer Medicine

Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology

ThrombiGlow: ‘Smart’ Multimodal Platelet Specific ‘Theranostic’ Drug Delivery Imaging Feb 1, 2017 - Jan 31, 2020
Cardiovascular diseases (CVD) including heart attacks and strokes constitute the leading cause of mortality in the UK. The pathology underlying CVD is called atherothrombosis and is a complex, multi-cellular-inflammatory disorder. Central to this is... Read More about ThrombiGlow: ‘Smart’ Multimodal Platelet Specific ‘Theranostic’ Drug Delivery Imaging.

Blood test for clinical therapy guidance of non-small cell lung cancer patients Jan 1, 2017 - Oct 31, 2022
Lung cancer is the most common cancer worldwide. NSCLC alone make up about 75% of all lung cancers and most hospitals currently test all NSCLC patients for EGFR mutations (pharmacogenomics) for treatment decision (personalised medicine) – i.e., patie... Read More about Blood test for clinical therapy guidance of non-small cell lung cancer patients.

The role of bacteria in the skin: Cold atmospheric plasma for the treatment of pathological skin healing Apr 1, 2017 - Mar 31, 2020
Chronic wounds remain a major area of unmet clinical need, with infection a principle contributing factor to wound chronicity. This project builds upon strong preliminary data suggesting that healing outcome can be directly linked to both wound micro... Read More about The role of bacteria in the skin: Cold atmospheric plasma for the treatment of pathological skin healing.

MICA: The role of arginase in chronic delayed wound healing Aug 1, 2016 - Oct 17, 2017

The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture. Jun 1, 2017 - May 31, 2018
Graves’ disease (GD) affects approximately 2% of adult women. Current treatments for GD include anti-thyroid drugs, radioiodine therapy and surgery, of which none tackle the underlying pathogenic process. Immunosuppressive agents are therefore of gro... Read More about The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture..